(Q46140539)

19 December 2017

title

The management of hypogonadism in aging male patients (English)

1 reference

19 December 2017

1 reference

2

1 reference

19 December 2017

author name string

Vishwamitra Sharma

series ordinal

1

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

19 December 2017

published in

Postgraduate Medicine

1 reference

19 December 2017

volume

121

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

113-121

1 reference

19 December 2017

Prevalence of symptomatic androgen deficiency in men.

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Prevalence and management of mild hypogonadism: introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Diagnosis of hypogonadism in the aging male

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Effects of testosterone on cognitive and brain aging in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

The role of androgens in cognition and brain aging in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Bioavailability of albumin-bound testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Testicular function in Klinefelter syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Endocrine disorders in men infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

An ensemble model of the male gonadal axis: illustrative application in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Central causes of hypogonadism—functional and organic

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Hypogonadism in hereditary hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

A simple screening method for detection of Klinefelter syndrome and other X-chromosome aneuploidies based on copy number of the androgen receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Androgens, Aging, and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Androgen cell signaling pathways involved in neuroprotective actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Androgen deficiency and hormone-replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Testosterone treatment comes of age: new options for hypogonadal men

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Discovery and therapeutic promise of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Commentary: Guideline for male testosterone therapy: a clinician's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.01.1960

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.01.1960

1 reference

19 December 2017

1 reference

19 December 2017